HIPEC After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer
This comparative effectiveness cohort study evaluates the safety and effectiveness of interval cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) compared with interval cytoreductive surgery alone in clinical practice for patients with advanced-stage ovarian cancer.
Source: JAMA Surgery - Category: Sports Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Ovarian Cancer | Ovaries | Sports Medicine | Study